OClawVPS.com
DMC Biotechnologies, Inc.
Edit

DMC Biotechnologies, Inc.

http://www.dmcbio.com/
Last activity: 07.04.2026
Active
Categories: ChemicalChemicalsEnergyTechEngineeringPlatformProductProductionSpecialtyTechnologyTime
DMC is a privately-held company, producing bio-based chemicals using fermentation. Many chemicals are too expensive today for broad market adoption, such as certain amino acids for animal feed or natural cleaning agents for personal care. These products can be made more affordably and reliably using our technology.

We believe in sustainability and economic viability. Our patented technology makes products with lower energy and resource use, with applications that can contribute to a more sustainable economy.
Followers
887
Mentions
18
Location: United States, Colorado, Boulder
Employees: 11-50
Total raised: $46.05M
Founded date: 2014

Investors 5

Funding Rounds 3

DateSeriesAmountInvestors
02.12.2021Series B$34MQuest for ...
09.07.2019Series A$10.3M-
09.01.2018-$1.75MCapricorn ...

Mentions in press and media 18

DateTitleDescription
07.04.2026LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. MarketThis collaboration brings to market a cleaner, more sustainable, and more reliable source of inositols.” — Jerry Whelan, Senior Vice President, Food & Nutrition at LBBSBOULDER, CO, UNITED STATES, April 7, 2026 /EINPresswire.com/ -- LBB ...
15.07.2025DMC Biotechnologies Introduces Fermented D-Chiro-Inositol, Further Expanding Portfolio of Clean-Label IngredientsNew sustainably produced ingredient supports formulators with supply security, consistency, and environmental advantages Fermentation enables higher purity and traceability, while also reducing environmental impact—a combination that’s incr...
03.06.2025Toyobo and DMC Biotechnologies Sign Joint Development Agreement to Advance Sustainable Chemical SolutionsThis collaboration reflects our shared commitment to delivering sustainable, cost-effective solutions to the chemical industry.” — Jim Flatt, CEO of DMC BiotechnologiesBOULDER, CO, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- DMC Biote...
07.05.2025DMC Biotechnologies Expands Ingredient Portfolio with Fermented Myo-InositolCompany introduces cleaner, more sustainable ingredient to support the growing demand for bio-based alternatives in the nutrition industry Fermented myo-inositol is part of our broader strategy to deliver ingredients that support long-term ...
27.06.2024Why Danone Bet on Precision Fermentation & ‘White Biotech’ for the Future of Food5 Mins Read French dairy giant Danone is part of a consortium that aims to scale up precision fermentation via a new open platform – in an interview, the company explains its thinking behind the move. Danone aims to ramp up its innovation c...
14.06.2024Danone to Open Precision Fermentation Center ‘Biotech Open Platform’ in France with Strategic PlayersFrench dairy giant Danone, engineered materials group Michelin, the US startup DMC Biotechnologies, and Crédit Agricole Centre France have partnered to create the Biotech Open Platform. The new center will focus on precision fermentation, a...
05.01.2022DMC Appoints Ashley Jenkins as CFOBoulder CA, USA: 5 January 2022 – DMC Biotechnologies has appointed Ashley Jenkins as Chief Financial Officer (CFO). Ashley joins DMC from Felix Energy where she has worked since 2013. Ashley joins DMC’s Boulder, Colorado office.
03.12.2021DMC Biotechnologies Closes $34M First Close of Series B FundingDMC Biotechnologies, a Boulder, CO and Durham, NC-based biobased chemical company that makes products using microbial fermentation, completed the first close of its Series B fundraising, raising $34m (USD). Backers included Cibus Enterprise...
02.12.2021Quest for Growth : invests 1.7 million USD in DMCPress release Leuven / 2 December 2021 QUEST FOR GROWTH Privak/pricaf, public alternative investment fund (AIF) with fixed capital under Belgian law Quest for Growth invests 1.7 million USD in DMC Biotechnologies DMC Biotechnologies has clo...
02.12.2021Capricorn Further Invests in DMC Series BLeuven, Belgium: 2 December 2021 – DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy V...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In